Inventor · disambiguated record
Pravin L. Kotian
Also filed as: KOTIAN PRAVIN · KOTIAN PRAVIN L
48 granted patents·24 pending applications·633 citations·filing 2000–2024
98Inventor score
Files withBIOCRYST PHARM INC58BABU YARLAGADDA S10BANTIA SHANTA1BIOCRYST PHARMACETICALS INC1ISLAND PHARMACEUTICALS LTD1
Top patents by PatentIndex Score
72 records- 0198US7560434B2AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jul 14, 2009·92 cites·29 claims
- 0297US11230530B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Jan 25, 2022·5 cites·22 claims
- 0397US11203574B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 21, 2021·5 cites·22 claims
- 0497US11192861B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 7, 2021·5 cites·27 claims
- 0597US10689346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 23, 2020·10 cites·38 claims
- 0697US10633345B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Apr 28, 2020·10 cites·25 claims
- 0797US10329260B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Jun 25, 2019·26 cites·45 claims
- 0897US10125102B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2015·Granted Nov 13, 2018·24 cites·16 claims
- 0997US7994139B2Antiviral therapeutic agentsBIOCRYST PHARM INC·Filed 2009·Granted Aug 9, 2011·81 cites·24 claims
- 1096US11708333B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·23 claims
- 1196US11708332B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·16 claims
- 1296US11685721B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 27, 2023·2 cites·33 claims
- 1396US7514410B2Hepatitis C therapiesBIOCRYST PHARM INC·Filed 2006·Granted Apr 7, 2009·80 cites·42 claims
- 1495US11708347B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·3 cites·9 claims
- 1595US11370774B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 28, 2022·4 cites·3 claims
- 1695US8440813B2Antiviral nucleoside analogsBABU YARLAGADDA S·Filed 2008·Granted May 14, 2013·42 cites·1 claims
- 1795US8133870B2Therapeutic furopyrimidines and thienopyrimidinesBABU YARLAGADDA S·Filed 2005·Granted Mar 13, 2012·32 cites·24 claims
- 1895US6699994B1Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2002·Granted Mar 2, 2004·87 cites·21 claims
- 1994US11866418B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jan 9, 2024·2 cites·17 claims
- 2093US11021458B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 1, 2021·5 cites·12 claims
- 2192US8163703B2Hepatitis C therapiesBABU YARLAGADDA S·Filed 2009·Granted Apr 24, 2012·27 cites·31 claims
- 2292US2025257040A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 2392US2025270171A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 2491US12043610B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jul 23, 2024·1 cites·9 claims
- 2591US11559515B2Indole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2020·Granted Jan 24, 2023·2 cites·19 claims
- 2690US11173159B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2019·Granted Nov 16, 2021·3 cites·20 claims
- 2790US9492452B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2014·Granted Nov 15, 2016·9 cites·30 claims
- 2889US10420769B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2018·Granted Sep 24, 2019·4 cites·20 claims
- 2989US10022375B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2016·Granted Jul 17, 2018·5 cites·32 claims
- 3089US6936719B2Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2003·Granted Aug 30, 2005·37 cites·18 claims
- 3188US12162838B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Dec 10, 2024·0 cites·28 claims
- 3288US12116346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Oct 15, 2024·0 cites·26 claims
- 3387US10849883B2Benzopyrazole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2017·Granted Dec 1, 2020·3 cites·21 claims
- 3486US11661426B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2018·Granted May 30, 2023·2 cites·42 claims
- 3586US2024294494A1Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 3685US6518299B1Substituted pyrrolidine compounds useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 2000·Granted Feb 11, 2003·13 cites·1 claims
- 3783US10562850B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2016·Granted Feb 18, 2020·2 cites·23 claims
- 3880US11066360B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jul 20, 2021·1 cites·20 claims
- 3979US2024376117A1Imidazole-containing inhibitors of alk2 kinaseBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 4078US12508266B2Methods and compositions for inhibition of polymeraseISLAND PHARMACEUTICALS LTD·Filed 2021·Granted Dec 30, 2025·0 cites·18 claims
- 4177US12054492B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2023·Granted Aug 6, 2024·0 cites·37 claims
- 4277US10759759B2Prodrugs of kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2017·Granted Sep 1, 2020·1 cites·30 claims
- 4377US9499554B2Anti-influenza compositions and methodsBIOCRYST PHARM INC·Filed 2014·Granted Nov 22, 2016·1 cites·24 claims
- 4477US7230119B2Process for the preparation of substituted pyrrolidine derivatives and intermediatesBIOCRYST PHARM INC·Filed 2005·Granted Jun 12, 2007·2 cites·10 claims
- 4576US12485109B2Pyrrolo 12.3-dipyrimidine compounds and analogues thereofBIOCRYST PHARM INC·Filed 2023·Granted Dec 2, 2025·0 cites·7 claims
- 4673US11975003B2Methods and compositions for treatment of Zika virus infectionBIOCRYST PHARM INC·Filed 2021·Granted May 7, 2024·0 cites·9 claims
- 4771US11807605B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Nov 7, 2023·0 cites·35 claims
- 4868US11618731B2Prodrugs of kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Apr 4, 2023·0 cites·13 claims
- 4968US10933066B2Methods and compositions for treatment of Zika virus infectionBIOCRYST PHARM INC·Filed 2019·Granted Mar 2, 2021·0 cites·12 claims
- 5065US9580428B2Compositions and methods for inhibiting viral polymeraseKOTIAN PRAVIN L·Filed 2013·Granted Feb 28, 2017·1 cites·16 claims
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Pravin L. Kotian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →